ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,951Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 127

$531K Total Retail Price of All Prescriptions

Rank: 6 out of 127

353 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

10% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 5,986 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $135 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 470 341 1 10
AMLODIPINE BESYLATE 417 316 2 1
LISINOPRIL 302 195 3 2
FUROSEMIDE 282 201 4 3
METOPROLOL TARTRATE 230 160 5 6
HYDROCHLOROTHIAZIDE 191 129 6 26
OMEPRAZOLE 182 101 7 20
LEVOTHYROXINE SODIUM 167 140 8 16
IBUPROFEN 157 116 9 51
CARVEDILOL 148 93 10 14
METFORMIN HCL 139 106 11 33
TRAZODONE HCL 134 101 12 35
DONEPEZIL HCL 133 132 13 32
WARFARIN SODIUM 132 95 14 24
OXCARBAZEPINE 124 92 15 78
RISPERIDONE 121 78 16 61
LOSARTAN POTASSIUM 118 83 17 12
GABAPENTIN 117 55 18 31
CLONIDINE HCL 100 54 19 8
GLIPIZIDE 98 93 20 64
HYDRALAZINE HCL 94 80 21 11
LACTULOSE 94 61 21 67
ATORVASTATIN CALCIUM 92 66 23 19
KLOR-CON 10 91 60 24 88
NAMENDA 87 87 25 45
TRAMADOL HCL 81 60 26 25
RANITIDINE HCL 80 34 27 43
LEVETIRACETAM 79 60 28 38
LANTUS 78 49 29 58
QUETIAPINE FUMARATE 73 62 30 58
RENVELA 70 37 31 5
CYCLOBENZAPRINE HCL 65 14 R 32 106
MIRTAZAPINE 63 50 33 36
OXYCODONE-ACETAMINOPHEN 62 11 S2 34 37
PREDNISONE 59 27 35 17
CLOPIDOGREL 55 41 36 47
NITROGLYCERIN PATCH 54 46 37 116
DIOVAN 54 42 37 30
NEXIUM 53 28 39 52
LANTUS SOLOSTAR 53 22 39 118
ATENOLOL 53 37 39 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 28 42 119
NIFEDIPINE ER 52 40 42 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.